Post-stroke patients have elevated levels of ACE2 in their lungs and altered systemic inflammatory responses, which facilitate SARS-CoV-2 binding and infection [15, 16]; and they often require continuous medical intervention, such as rehabilitation therapy, potentially making them more susceptible to nosocomial infection. This evidence concerns the gene ACE2 and Stroke.